Login
Contact Us
Search

Get PrismRA
The PrismRA Result
For Physicians
Affordability
Lab and Sample Collection

Select Page

Certifications

CLIA Certification

HFAP Accreditation

HFAP Seal

California Lab License

Maryland Licensure

Pennsylvania Lab License

Rhode Island Lab License

College of American Pathologists Certificate

PrismRA is a molecular signature response classifier (MSRC) that uses gene expression features, clinical features and anti-cyclic citrullinated protein (anti-CCP) antibody to detect a signature of non-response to tumor necrosis factor-α inhibitors (TNFi) for patients with rheumatoid arthritis. PrismRA predicts the patient’s likelihood of inadequately responding to all TNFi therapies. Response is defined as achieving ACR50 at 6 months. The PrismRA result is reported on a continuous 1 to 25 scale. The higher the score, the more likely the patient will have an inadequate response to TNFi therapies; the lower the score, the less likely the patient will have an inadequate response to TNFi therapies. However, a low score does not ensure a positive response to TNFi therapies.

PrismRA for Patients

How PrismRA Helps You
Get PrismRA
The PrismRA Result
Affordability
Billing FAQs

For Physicians

The PrismRA Solution
PrismRA Development
The PrismRA Result Report
Ordering PrismRA
Publications & Tech Specs

Resources

Download Patient Brochure
Download Billing Brochure
Financial Assistance
Patient Billing Portal
How to Talk to Your Doctor
Global Healthy Living Foundation

Scipher Medicine

Contact Us
PrismRA Lab Certifications
Notice of Privacy Practices
Privacy Policy
Terms of Use
Cookies Acknowledgement
Patient Opt-Out Information
Right to Receive a Good Faith Estimate

2022 Scipher Medicine Corporation. All rights reserved. Scipher Medicine, PrismRA, and their logos are registered trademarks in the United States and other jurisdiction. RA-SA0004-002-220510

This website uses cookies in order to personalize content based on your interests, measure the performance of this website and derive insights about the audience who visits our website and content. Click accept to consent to our use of cookies. For more detailed information about the use of cookies on this website and how you manage or withdraw your consent at any time, please review our Cookies Policy.